Author:
Rajan Sindhu,Dickson Lorna M.,Mathew Elizabeth,Orr Caitlin M.O.,Ellenbroek Johanne H.,Philipson Louis H.,Wicksteed Barton
Funder
National Institutes of Health
University of Chicago Diabetes Research and Training Center
Diabetes Fonds
Subject
Cell Biology,Molecular Biology
Reference56 articles.
1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes;Drucker;Lancet,2006
2. Mechanisms of action of glucagon-like peptide 1 in the pancreas;Doyle;Pharmacology & Therapeutics,2007
3. Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A review;Furman;The Journal of Pharmacy and Pharmacology,2004
4. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study;Zander;Lancet,2002
5. One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial;Bunck;Diabetes Care,2009
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献